Platform Development (Stellar mRNA)
Infectious Diseases, Rare Diseases, Cancers
Pre-clinicalActive
Key Facts
Indication
Infectious Diseases, Rare Diseases, Cancers
Phase
Pre-clinical
Status
Active
Company
About Celestial Therapeutics
Celestial Therapeutics is an early-stage biotech leveraging proprietary 'Stellar mRNA' and novel lipid platforms to develop next-generation antivirals, anti-inflammatories, and mRNA vaccines. The company's science is rooted in licensed technology from Harvard University and research from National Jewish Health, targeting a broad range of infectious, rare, and oncological diseases. With a seasoned founding team and backing from notable accelerators and partners like CEPI, Celestial is positioned in the high-growth mRNA and antiviral therapeutics space, though it remains in the pre-clinical development phase.
View full company profile